The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Heparin and Low-Molecular-Weight Heparin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
Self-citationSchömig, A., Neumann, F.-J., Kastrati, A., Schühlen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E.-M., Richardt, G., Alt, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341702 · Cited by 2,028
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
Hemostasis and Thrombosis: Basic Principles and Clinical Practice.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-504_7 · Cited by 1,854
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G. G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A. A., Premmereur, J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370702 · Cited by 1,424
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Rosenberg, R. D., & Damus, P. S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43472-8 · Cited by 1,356
ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
Barritt, D. W., & Jordan, S. C. (1960) · The Lancet · doi:10.1016/s0140-6736(60)92299-6 · Cited by 1,354
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
Théroux, P., Ouimet, H., McCans, J., Latour, J.-G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191701 · Cited by 1,276
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Self-citationWeitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Self-citationKoopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G. G., Bernink, P. J. L. M., Salein, D., Bayes de Luna, A., Fox, K., Lablanche, J.-M., Radley, D., et al. (1999) · Circulation · doi:10.1161/01.cir.100.15.1593 · Cited by 1,052
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
Hirsh, J., & Levine, M. (1992) · Blood · doi:10.1182/blood.v79.1.1.bloodjournal7911 · Cited by 894
Self-citationA 14-year study of heparin-induced thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00258-6 · Cited by 886
Self-citationOates, J. A., Wood, A. J. J., & Hirsh, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242206 · Cited by 830
Self-citationMeyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Suppression by heparin of smooth muscle cell proliferation in injured arteries
CLOWES, A. W., & KARNOWSKY, M. J. (1977) · Nature · doi:10.1038/265625a0 · Cited by 790
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.-P., Azarian, R., Laurent, M., Hirsch, J.-L., Ferrari, E., Bosson, J.-L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371002 · Cited by 782
The RISC Group (1990) · The Lancet · doi:10.1016/0140-6736(90)92336-g · Cited by 781
Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
Folts, J. D., Crowell, E. B., & Rowe, G. G. (1976) · Circulation · doi:10.1161/01.cir.54.3.365 · Cited by 750
Raschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Self-citationTurpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
Hull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
Self-citationSimoons, M. L. (1996) · RePub (Erasmus University Rotterdam) · Cited by 706
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Madden, C. (1991) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81237-5 · Cited by 691
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Nurmohamed, M. T., Buller, H. R., Dekker, E., Hommes, D. W., Rosendaal, F. R., Briet, E., Rosendaal, F. R., & Vandenbroucke, J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93223-a · Cited by 668
Basu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
Self-citationChoay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Büller, H. R., Davidson, B. L., Decousus, H., Gallus, A., Gent, M., Piovella, F., Prins, M. H., Raskob, G., Segers, A. E. M., Cariou, R., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00007 · Cited by 617
Haemostasis in Normal Pregnancy
Stirling, Y., Woolf, L., North, W. R. S., Seghatchian, M. J., & Meade, T. W. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661167 · Cited by 600
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Heparin-induced Thrombocytopenia: Towards Consensus
Warkentin, T. E., Chong, B. H., & Greinacher, A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614206 · Cited by 542
Self-citationTurpie, A. G. G., Levine, M., Hirsh, J., Carter, C. J., Jay, R. M., Powers, P. J., Andrew, M. E., Hull, R. D., & Gent, M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610093151503 · Cited by 530
Self-citationTHE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., & Ludwig, K. (1997) · Circulation · doi:10.1161/01.cir.96.1.61 · Cited by 526
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Self-citationMechanism of the anticoagulant action of heparin
Bj�rk, I., & Lindahl, U. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421226 · Cited by 494
Greinacher, A., Pötzsch, B., Amiral, J., Dummel, V., Eichner, A., & Mueller-Eckhardt, C. (1994) · PubMed · Cited by 492
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Antman, E. M. (1996) · Circulation · doi:10.1161/01.cir.94.5.911 · Cited by 485
Heparin-induced thrombocytopenia: laboratory studies
Kelton, J., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., & Murphy, W. (1988) · Blood · doi:10.1182/blood.v72.3.925.925 · Cited by 483
Oler, A. (1996) · JAMA · doi:10.1001/jama.276.10.811 · Cited by 483
Greinacher, A., Völpel, H., Janssens, U., Hach-Wunderle, V., Kemkes-Matthes, B., Eichler, P., Mueller-Velten, H. G., & Pötzsch, B. (1999) · Circulation · doi:10.1161/01.cir.99.1.73 · Cited by 482
Heparin-Associated Thrombocytopenia
KING, D. J., & KELTON, J. G. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-4-535 · Cited by 480
Brandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
Warkentin, T., Hayward, C., Boshkov, L., Santos, A., Sheppard, J., Bode, A., & Kelton, J. (1994) · Blood · doi:10.1182/blood.v84.11.3691.bloodjournal84113691 · Cited by 478
Self-citationReactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Letter: The consultants' contract.
Plumley, P. F. (1974) · PubMed · Cited by 460
Actions and Interactions of Antithrombin and Heparin
Bleich, H. L., Boro, E. S., & Rosenberg, R. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197501162920307 · Cited by 459
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Hull, R. D., Raskob, G. E., Pineo, G. F., Rosenbloom, D., Evans, W. E., Mallory, T. H., Anquist, K., Smith, F., Hughes, G. W., Green, D., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291902 · Cited by 440
Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)
Magnani, H. N. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649626 · Cited by 435
Management of Heparin Therapy: Controlled Prospective Trial
Salzman, E. W., Deykin, D., Shapiro, R. M., & Rosenberg, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505152922002 · Cited by 435
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.
Braunwald, E., Jones, R. H., Mark, D. B., Brown, J., Brown, L., Cheitlin, M. D., Concannon, C. A., Cowan, M., Edwards, C., & Fuster, V (1994) · Circulation · doi:10.1161/01.cir.90.1.613 · Cited by 418
Levine, M. N. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.49 · Cited by 403
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
Haustein, K.-O. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996417 · Cited by 387
Dahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Cohen, M., Adams, P. C., Parry, G., Xiong, J., Chamberlain, D., Wieczorek, I., Fox, K. A., Chesebro, J. H., Strain, J., & Keller, C. (1994) · Circulation · doi:10.1161/01.cir.89.1.81 · Cited by 378
Low molecular weight heparin in prevention of perioperative thrombosis.
Leizorovicz, A., Haugh, M. C., Chapuis, F. R., Samama, M. M., & Boissel, J. P. (1992) · BMJ · doi:10.1136/bmj.305.6859.913 · Cited by 378
Siragusa, S., Cosmi, B., Piovella, F., Hirsh, J., & Ginsberg, J. S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89484-3 · Cited by 373
Self-citationStructure of the antithrombin-binding site in heparin.
Lindahl, U., Bäckström, G., Höök, M., Thunberg, L., Fransson, L. A., & Linker, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3198 · Cited by 368
Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
Swahn, E., & Wallentin, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00486-4 · Cited by 354
Monréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Hogg, P. J., & Jackson, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3619 · Cited by 347
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L., & Lindahl, U. (1984) · Biochemical Journal · doi:10.1042/bj2180725 · Cited by 342
Extension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Jordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70431-1 · Cited by 333
Carter, C., Kelton, J., Hirsh, J., Cerskus, A., Santos, A., & Gent, M. (1982) · Blood · doi:10.1182/blood.v59.6.1239.1239 · Cited by 331
Self-citationHeras, M., Chesebro, J. H., Penny, W. J., Bailey, K. R., Badimon, L., & Fuster, V (1989) · Circulation · doi:10.1161/01.cir.79.3.657 · Cited by 331
Establishing a Therapeutic Range for Heparin Therapy
Brill-Edwards, P., Ginsberg, J. S., Johnston, M., & Hirsh, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00002 · Cited by 329
Self-citationProtamine: a review of its toxicity.
Horrow, J. C. (1985) · PubMed · Cited by 329
Gurfinkel, E. P., Manos, E. J., Mejaíl, R. I., Cerdá, M. A., Duronto, E. A., García, C. N., Daroca, A. M., & Mautner, B. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80001-w · Cited by 326
Casu, B., Oreste, P., Torri, G., Zoppetti, G., Choay, J., Lormeau, J. C., Petitou, M., & Sinaɕ, P. (1981) · Biochemical Journal · doi:10.1042/bj1970599 · Cited by 326
Turpie, A. G. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., Cairns, J. A., Skingley, L., Hirsh, J., & Gent, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200604 · Cited by 323
Self-citation(1999) · The Lancet · doi:10.1016/s0140-6736(98)07332-2 · Cited by 322
Castellot, J. J., Favreau, L. V., Karnovsky, M. J., & Rosenberg, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33750-5 · Cited by 310
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Leclerc, J., Powers, P. J., Jay, R. M., & Neemeh, J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-545 · Cited by 308
Self-citationLeizorovicz, A., Simonneau, G., Decousus, H., & Boissel, J. P. (1994) · BMJ · doi:10.1136/bmj.309.6950.299 · Cited by 306
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Monreal, M., Lafoz, E., Olive, A., del Rio, L., & Vedia, C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642376 · Cited by 299
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
Collins, R., Peto, R., Baigent, C., & Sleight, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361207 · Cited by 297
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.
Théroux, P., Waters, D., Qiu, S., McCans, J., de Guise, P., & Juneau, M. (1993) · Circulation · doi:10.1161/01.cir.88.5.2045 · Cited by 296
de Bono, D. P., Simoons, M. L., Tijssen, J., Arnold, A. E., Betriu, A., Burgersdijk, C., Lopez Bescos, L., Mueller, E., Pfisterer, M., & Van de Werf, F. (1992) · Heart · doi:10.1136/hrt.67.2.122 · Cited by 295
COLLINS, R., SCRIMGEOUR, A., YUSUF, S., PETO, R., & Roizen, M. F. (1989) · Survey of Anesthesiology · doi:10.1097/00132586-198902000-00032 · Cited by 294
Treatment of Deep Venous Thrombosis With Low-Molecular-Weight Heparins: A Meta-analysis
Lensing, A. W. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430060059007 · Cited by 285
Heparin-Induced Thrombocytopenia Associated with Fondaparinux
(2007) · New England Journal of Medicine · doi:10.1056/nejmc070346 · Cited by 283
Correlation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Granger, C. B., Hirsh, J., Califf, R. M., Col, J., White, H. D., Betriu, A., Woodlief, L. H., Lee, K. L., Bovill, E. G., Simes, R. J., et al. (1996) · Circulation · doi:10.1161/01.cir.93.5.870 · Cited by 281
Self-citationLeyvraz, P. F., Richard, J., Bachmann, F., van Melle, G., Treyvaud, J.-M., Livio, J.-J., & Candardjis, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310203091605 · Cited by 281
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 278
Heparin kinetics in venous thrombosis and pulmonary embolism.
Hirsh, J., van Aken, W. G., Gallus, A. S., Dollery, C. T., Cade, J. F., & Yung, W. L. (1976) · Circulation · doi:10.1161/01.cir.53.4.691 · Cited by 277
Self-citationHighly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis
Abildgaard, U. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076981 · Cited by 275
A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
Barbour, L. A., Kick, S. D., Steiner, J. F., LoVerde, M. E., Heddleston, L. N., Lear, J. L., Baron, A. E., & Bartón, P. L. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70299-3 · Cited by 272
A standard heparin nomogram for the management of heparin therapy
Cruickshank, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.2.333 · Cited by 266
Landefeld, C. S., Cook, E. F., Flatley, M., Weisberg, M., & Goldman, L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90004-0 · Cited by 264
Hull, R. D. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.22.2562 · Cited by 261
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Hull, R. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.8.1589 · Cited by 260
Francis, C. W. (1983) · JAMA · doi:10.1001/jama.1983.03330270038029 · Cited by 256
Kinetics of intravenously administered heparin in normal humans
de Swart, C., Nijmeyer, B., Roelofs, J., & Sixma, J. (1982) · Blood · doi:10.1182/blood.v60.6.1251.1251 · Cited by 253
Danielsson, A., Raub, E., Lindahl, U., & Björk, I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66735-3 · Cited by 252
Plasma P-selectin is increased in thrombotic consumptive platelet disorders
Chong, B., Murray, B., Berndt, M., Dunlop, L., Brighton, T., & Chesterman, C. (1994) · Blood · doi:10.1182/blood.v83.6.1535.1535 · Cited by 250
Laposata, M., Green, D., Cott, E. M. V., Barrowcliffe, T. W., Goodnight, S. H., & Sosolik, R. C. (1998) · PubMed · Cited by 249
HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPY
Mant, M., Thong, K. L., Birtwhistle, R., O'Brien, B., Hammond, G., & Grace, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92388-1 · Cited by 242
Olson, J. D., Arkin, C. F., Brandt, J. T., Cunningham, M. T., Giles, A., Koepke, J. A., & Witte, D. L. (1998) · PubMed · Cited by 241
Holmer, E., Kurachi, K., & Söderström, G. (1981) · Biochemical Journal · doi:10.1042/bj1930395 · Cited by 239
A Standard Heparin Nomogram for the Management of Heparin Therapy
Cruickshank, M. K. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400020085018 · Cited by 237
Brinkhous, K. M., Smith, H. P., Warner, E. D., & Seegers, W. H. (1939) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1939.125.4.683 · Cited by 234
Leclerc, J. R., Geerts, W. H., Desjardins, L., Laflamme, G. H., l'Esperance, B., Demers, C., Kassis, J., Cruickshank, M., Whitman, L., & Delorme, F. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00001 · Cited by 233
Binding of heparin on the surface of cultured human endothelial cells
Glimelius, B., Busch, C., & Höök, M. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90271-2 · Cited by 233
Simonneau, G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130045005 · Cited by 232
The Mode of Action of Heparin in Plasma
Béguin, S., Lindhout, T., & Hemker, H. C. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646990 · Cited by 230
Nieuwenhuis, H., Albada, J., Banga, J., & Sixma, J. (1991) · Blood · doi:10.1182/blood.v78.9.2337.2337 · Cited by 226
Olson, S. T., Srinivasan, K. R., Björk, I., & Shore, J. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68557-1 · Cited by 226
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
RANDOMISED CONTROLLED TRIAL OF SUBCUTANEOUS CALCIUM-HEPARIN IN ACUTE MYOCARDIAL INFARCTION
(1989) · The Lancet · doi:10.1016/s0140-6736(89)90371-1 · Cited by 223
PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW-DOSE HEPARIN
Gruber, U., Duckert, F., Fridrich, R., Rem, J., Torhorst, J., Kakkar, V. V., Corrigan, T. P., Fossard, D. P., Sutherland, I., & Thirlwell, J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91213-2 · Cited by 221
Leclerc, J. R., Geerts, W. H., Desjardins, L., Jobin, F., Laroche, F., Delorme, F., Haviernick, S., Atkinson, S., & Bourgouine, J. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648463 · Cited by 220
Daenen, S., & de Vries-Hospers, H. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91741-2 · Cited by 219
Risks to the Fetus of Anticoagulant Therapy During Pregnancy
Ginsberg, J. S., Hirsh, J., Turner, D. C., Levine, M. N., & Burrows, R. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646558 · Cited by 218
Self-citationPowers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
Kuderer, N. M., Khorana, A. A., Lyman, G. H., & Francis, C. W. (2007) · Cancer · doi:10.1002/cncr.22892 · Cited by 212
Lindmarker, P., Holmström, M., Granqvist, S., Johnsson, H., & Lockner, D. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648836 · Cited by 210
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
Hettiarachchi, R., Smorenburg, S., Ginsberg, J., Levine, M., Prins, M., & Büller, H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615937 · Cited by 206
Randomized Prospective Trial of Continuous vs Intermittent Heparin Therapy
Glazier, R. L. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270130027021 · Cited by 205
Bar-Shavit, R., Eldor, A., & Vlodavsky, I. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114272 · Cited by 205
Lijnen, H. R., Hoylaerts, M., & Collen, D. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32737-6 · Cited by 200
Turpie, A. G., Hirsh, J., Jay, R., Andrew, M., Hull, R., Levine, M., Carter, C., Powers, P., Magnani, H., & Gent, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90173-5 · Cited by 200
Self-citationDahan, R., Houlbert, D., Caulin, C., Cuzin, E., Viltart, C., Woler, M., & Segrestaa, J. M. (1986) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000215286 · Cited by 199
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
Sobel, M., McNeill, P. M., Carlson, P. L., Kermode, J. C., Adelman, B., Conroy, R., & Marques, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115198 · Cited by 197
Collins, R., MacMahon, S., Flather, M., Baigent, C., Remvig, L., Mortensen, S., Appleby, P., Godwin, J., Yusuf, S., & Peto, R. (1996) · BMJ · doi:10.1136/bmj.313.7058.652 · Cited by 196
Binding and endocytosis of heparin by human endothelial cells in culture
Bârzu, T., Molho, P., Tobelem, G., Petitou, M., & Caen, J. (1985) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(85)90177-6 · Cited by 192
LAZO‐LANGNER, A., GOSS, G. D., SPAANS, J. N., & RODGER, M. A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02427.x · Cited by 191
Patrono, C., Coller, B., Dalen, J. E., Fuster, V., Gent, M., Harker, L. A., Hirsh, J., & Roth, G. (1998) · Chest · doi:10.1378/chest.114.5_supplement.470s · Cited by 190
Self-citationForestier, F., Daffos, F., & Capella-Pavlovsky, M. (1984) · Thrombosis Research · doi:10.1016/0049-3848(84)90260-3 · Cited by 189
Reduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
HALKIN, H., GOLDBERG, J., MODAN, M., & MODAN, B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-561 · Cited by 187
Multiple functional domains of the heparin molecule.
Oosta, G. M., Gardner, W. T., Beeler, D. L., & Rosenberg, R. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.829 · Cited by 187
Chiu, H., Hirsh, J., Yung, W., Regoeczi, E., & Gent, M. (1977) · Blood · doi:10.1182/blood.v49.2.171.171 · Cited by 183
Self-citationDeterminants of donor platelet variability when testing for heparin-induced thrombocytopenia.
Warkentin, T. E., Hayward, C. P. M., Smith, C., Kelly, P. M., & Kelton, J. G. (1992) · PubMed · Cited by 182
Self-citationHandeland, G. F., Abildgaard, U., Holm, H. A., & Arnesen, K. E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280041 · Cited by 181
Olson, S. T., & Shore, J. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33366-0 · Cited by 180
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Söderström, G. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90159-2 · Cited by 172
Muir, J. M., Hirsh, J., Weitz, J. I., Andrew, M., Young, E., & Shaughnessy, S. G. (1997) · Blood · doi:10.1182/blood.v89.9.3236 · Cited by 171
Self-citationPreissner, K. T., & Müller-Berghaus, G. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45343-4 · Cited by 170
Neri Serneri, G. G., Gensini, G. F., Poggesi, L., Trotta, F., Modesti, P. A., Boddi, M., Ieri, A., Margheri, M., Casolo, G. C., Bini, M., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90407-v · Cited by 170
Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin-Induced Skin Necrosis
WHITE, P. W., SADD, J. R., & NENSEL, R. E. (1979) · Annals of Surgery · doi:10.1097/00000658-197911000-00007 · Cited by 167
Frydman, A. M., Bara, L., Roux, Y. H., Woler, M., Chauliac, F., & Samama, M. M. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03184.x · Cited by 166
Holmer, E., Mattsson, C., & Nilsson, S. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90089-5 · Cited by 164
Hommes, D. W., Bura, A., Mazzolai, L., Büller, H. R., & ten Cate, J. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-279 · Cited by 163
Eichler, P., Budde, U., Haas, S., Kroll, H., Loreth, R. M., Meyer, O., Pachmann, U., Pötzsch, B., Schabel, A., Albrecht, D., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614536 · Cited by 161
Zacharski, L. R., & Ornstein, D. L. (1998) · PubMed · Cited by 159
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
Muir, J., Andrew, M., Hirsh, J., Weitz, J., Young, E., Deschamps, P., & Shaughnessy, S. (1996) · Blood · doi:10.1182/blood.v88.4.1314.bloodjournal8841314 · Cited by 157
Self-citationThe effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
Shaughnessy, S., Young, E., Deschamps, P., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1368.bloodjournal8641368 · Cited by 152
Stewart, W. J., McSweeney, S. M., Kellett, M. A., et al. (1984) · Circulation · doi:10.1161/01.cir.70.5.788 · Cited by 152
Ninet, J., Bachet, P., Prandoni, P., Ruol, A., Vigo, M., Barret, A., Mericq, O., Boneu, B., Janvier, G., Duroux, P., et al. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647660 · Cited by 148
The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and Humans
Olsson, P., Lagergren, H., & Ek, S. (1963) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1963.tb17446.x · Cited by 147
Bleeding associated with antithrombotic therapy.
Jg, K., & Hirsh, J. (1980) · PubMed · Cited by 147
Self-citationHemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
Fernandez, F., Nguyên, P., van Ryn, J., Ofosu, F. A., Hirsh, J., & Buchanan, M. R. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90094-0 · Cited by 139
Self-citationFondaparinux for the treatment of patients with acute heparininduced thrombocytopenia
Finch, C. K., Howard, A. H., Minhas, S., & Lobo, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0252 · Cited by 139
Four Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection
Johnson, E. A., Kirkwood, T. B. L., Stirling, Y., et al. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648001 · Cited by 137
Evidence for a heparin-induced conformational change on antithrombin III
Villanueva, G. B., & Danishefsky, I. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90374-6 · Cited by 137
Fiessinger, J., Fernández, M. F. L., Gatterer, E., Granqvist, S., Kher, A., Olsson, C. G., & Söderberg, K. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650553 · Cited by 136
Atha, D. H., Lormeau, J. C., Petitou, M., ROSENBERG, R. D., & Choay, J. (1987) · Biochemistry · doi:10.1021/bi00394a024 · Cited by 136
Heparin kinetics determined by three assay methods
Bjornsson, T. D., Wolfram, K. M., & Kitchell, B. B. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.16 · Cited by 136
Physician Practices in the Treatment of Pulmonary Embolism and Deep Venous Thrombosis
Wheeler, A. P. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380060085018 · Cited by 135
Nesheim, M. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43920-2 · Cited by 131
Bone mineral density during long-term prophylaxis with heparin in pregnancy
Dahlman, T. C., Sjöberg, H. E., & Ringertz, H. G. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70149-0 · Cited by 131
Oral Delivery of Anticoagulant Doses of Heparin
Baughman, R., Kapoor, S. C., Agarwal, R., Kisicki, J. C., Catella-Lawson, F., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.16.1610 · Cited by 129
An objective study of alternative methods of heparin administration
Bentley, P. G., Kakkar, V. V., Scully, M. F., MacGREGOR, I. R., Webb, P. J., Chan, P. S., & Jones, N. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90182-6 · Cited by 126
Vascular sequestration of heparin
Mahadoo, J., Hiebert, L. M., & Jaques, L. B. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90087-7 · Cited by 126
Ofosu, F. A., Siè, P., Modi, G. J., Fernandez, F., Buchanan, M. R., Blajchman, M. A., Boneu, B., & Hirsh, J. (1987) · Biochemical Journal · doi:10.1042/bj2430579 · Cited by 123
Self-citationHeparin-Induced Thrombocytopenia
Warkentin, T. E. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.06.004 · Cited by 123
Self-citationMassonnet-Castel, S., Pélissier, E., Bara, L., Terrier, E., Abry, B., Guibourt, P., Swanson, J., Jaulmes, B., Carpentier, A., & Samama, M. M. (2009) · Haemostasis · doi:10.1159/000215283 · Cited by 122
The Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke, R. A., Gollihare, B., & Peirce, J. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140067006 · Cited by 120
Self-citationForestier, F., Daffos, F., Rainaut, M., & Toulemonde, F. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651102 · Cited by 118
Pepine, C. J., & Holmes, D. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00322-1 · Cited by 117
Impairment by Heparin of Primary Haemostasis and Platelet [14C]5‐Hydroxytryptamine Release
Heiden, D., Mielke, C. H., & Rodvien, R. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb00666.x · Cited by 117
Hoylaerts, M., Owen, W. G., & Collen, D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91066-5 · Cited by 117
Factor‐Xa Inactivation by Antithrombin III
Marciniak, E. (1973) · British Journal of Haematology · doi:10.1111/j.1365-2141.1973.tb01662.x · Cited by 116
Heparin therapy: A randomized prospective study
Wilson, J. R., & Lampman, J. H. (1979) · American Heart Journal · doi:10.1016/0002-8703(79)90349-1 · Cited by 116
Hirsh, J., & Weitz, J. I. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09233-2 · Cited by 114
Self-citationCatabolism of low-dose heparin in man
Dawes, J., & Pepper, D. S. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90004-5 · Cited by 113
Friedman, R. J., Davidson, B. L., Heit, J. A., Kessler, C. M., Elliott, C. G., Cabanas, V., Chenault, C. S., Dall, D. M., CHANDLER, D. R., Drennan, D. B., et al. (1994) · Cited by 112
Gent, M., Hirsh, J., Ginsberg, J., Powers, P., Levine, M. N., Geerts, W. H., Jay, R. M., Leclerc, J. E., Neemeh, J. A., & Turpie, A. G. G. (1996) · Circulation · doi:10.1161/01.cir.93.1.80 · Cited by 109
Self-citationHeparin with two binding sites for antithrombin or platelet factor 4.
Jordan, R. E., Favreau, L. V., Braswell, E. H., & ROSENBERG, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68378-x · Cited by 107
Cited by
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181940 · Cited by 1,853
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Self-citation
Metadata
- Authors
- Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 114
- Issue
- 5
- Pages
- 489S-510S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2063207586
- Cited by
- 1,031
- References
- 280
- FWCI
- 35.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.